Understanding molecular mechanism and biological siginificance of dynamic fluctuation and heterogeneity of gene expression in ES cells and in the early mouse embryo
Understanding molecular mechanism and biological siginificance of dynamic fluctuation and heterogeneity of gene expression in ES cells and in the early mouse embryo
批准号:
158972463
负责人:
Dr. Takashi Hiiragi
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2009
资助国家:
德国
项目状态:
已结题
起止时间:
2008-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For the progress in stem cell research, it is essential to understand the molecular nature of pluripotency in embryonic stem (ES) cells. While pluripotency has been assumed to be a “static” status of a particular cell type, with ES cells being a homogeneous population, recent findings in mouse ES cells and early embryos suggest that it may in fact represent a certain condition of dynamic equilibrium of heterogeneous populations. In undifferentiated ES cells, a number of subpopulations are identified in terms of expression of pluripotency genes. Consistently, mouse embryonic cells that develop to form the pluripotent inner cell mass (ICM) in blastocyst, exhibit highly heterogeneous, and presumably stochastic, expression pattern for the lineage markers.The primary aim of this project is to understand the unique principle underlying maintenance of the pluripotent ES cells and formation of the ICM in the mouse embryo. In particular, dynamic spatiotemporal change in gene expression will be fully characterized by 4D live-imaging ES cell culture and mouse embryonic development. We will focus on Nanog and Stella genes, and investigate the role of epigenetic markings in the regulation of gene expression variation. Biological significance of the dynamic heterogeneity will be explored in ES cells and in mouse embryos by manipulating the molecular components and epigenetic markings under equilibrium. An attractive hypothesis is that this dynamic nature may be an essential feature of pluripotency and interaction of distinct subpopulations may be required for propagation of the pluripotent status. Full understanding of the dynamic equilibrium at molecular and systems level will provide insight into pluripotency maintenance in ES cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular characterisation of the establishment of and exit from pluripotency in the mouse embryo by combining live-imaging and single-cell RNA-seq
-
批准号:266274777
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Dr. Takashi Hiiragi
-
依托单位:
Molecular mechanism of natural pluripotency establishment in the early mouse embryo based on single-cell gene expression profile
-
批准号:66168481
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Dr. Takashi Hiiragi
-
依托单位:
Identification of the most reprogramming-potent oocyte for more efficient cloning and for a long-term approach to the isolation of reprogramming factor(s)
-
批准号:5449669
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Dr. Takashi Hiiragi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: